← Leaderboards
Xuefeng Liu
Ohio State University
$6,815,737
Attributed
$6,815,737
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,815,737 · 5
By mechanism
R01$3,512,419 · 2
U01$1,783,393 · 1
R33$1,153,979 · 1
R21$365,946 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Jessie L.-S. Au$10,705,345
- Sung Ok Yoon$8,885,626
- Electra D. Paskett$38,729,537
- Cynthia Timmers$514,769
- Andrew Gunderson$830,678
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseCellsCancer PatientProtocols DocumentationSuccessTechnologyEuropeanMalignant NeoplasmsMutationLaboratoriesTumorCell ModelUrologyTherapeutic AgentsCancer CenterIn VitroSpecimenPatient ResponseDiagnosisOperative Surgical ProceduresCell Culture TechniquesMedicalMortalityPaper
Grant awards (16)
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker â in Monitoring Response and Recurrence of Bladder Cancer$1,080,844
U01 · FY2025 · CA · contact PI
Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men$537,842
R01 · FY2025 · CA · contact PI
Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men$510,952
R01 · FY2024 · CA · contact PI
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker â in Monitoring Response and Recurrence of Bladder Cancer$342,268
U01 · FY2024 · CA · contact PI
Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men$537,842
R01 · FY2023 · CA · contact PI
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics$383,927
R33 · FY2023 · CA · contact PI
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker â in Monitoring Response and Recurrence of Bladder Cancer$360,281
U01 · FY2023 · CA · contact PI
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)$471,066
R01 · FY2022 · CA · contact PI
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics$379,392
R33 · FY2022 · CA · contact PI
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)$482,155
R01 · FY2021 · CA · contact PI
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics$390,660
R33 · FY2021 · CA · contact PI
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)$365,015
R01 · FY2020 · CA · contact PI
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)$114,328
R01 · FY2020 · CA · contact PI
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)$493,219
R01 · FY2019 · CA · contact PI
NON-CANONICAL FUNCTIONS OF HTERT IN CELL IMMORTALIZATION BY HPV$196,840
R21 · FY2014 · CA · contact PI
NON-CANONICAL FUNCTIONS OF HTERT IN CELL IMMORTALIZATION BY HPV$169,106
R21 · FY2013 · CA · contact PI